Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)

Siren Biotechnology, a gene therapy company pioneering Universal AAV Immuno-Gene Therapies for Cancerâ„¢, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M translational research grant to support the development of novel AAV immuno-gene therapies for cancer.

Nicole Paulk, PhD, is the lead inventor.

More